Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma

Cutaneous and Ocular Toxicology

Volumn 32, Issue 4, 2013, Pages 341-343

  Modjtahedi, Bobeck S ^a   Maibach, Howard ^b   Park, Susanna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Drug reaction; Immunology; Ipilimumab; Melanoma; T cell

Indexed keywords

BEVACIZUMAB; IPILIMUMAB; RANIBIZUMAB;

AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; BOWEL DISTRESS; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ENTEROPATHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; METASTATIC MELANOMA; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRURITUS; PSEUDOPHAKIA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITILIGO;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHOROIDAL NEOVASCULARIZATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; MELANOMA; RETINA;

EID: 84883182322     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2013.781618     Document Type: Article

References (5)

1. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-723
2. Wong RK, Lee JK, Huang JJ. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of Vogt-Koyanagi-Harada syndrome. Retinal Cases Brief Rep 2012;6:423-426
3. Renouf DJ, Velazquez-Martin JP, Simpson R, et al. Ocular toxicity of targeted therapies. J Clin Oncol 2012;30:3277-3286
4. Borodic G, Hinkle DM, Cia Y. Drug-induced graves disease from CTLA-4 receptor suppression. Ophthal Plast Reconstr Surg 2011;27:e87-e88
5. Patel M, Chan CC. Immunopathological aspects of agerelated macular degeneration. Semin Immunopathol 2008;30: 97-110